Research

Energy balance

More studies are needed to support the long-term effects of long-acting amylin analogues in relevant populations.

Practitioners should be aware that while promising, the long-term efficacy of these treatments is not yet established.

StrongQualifiesmedium confidence
Long-acting amylin analogues have emerged as a possible pharmacotherapy against obesity, but more studies are needed to support the utility and long-term effects of this strategy in relevant populations.
David S. Mathiesen et al. · Current Opinion in Endocrinology Diabetes and Obesity · 2022

Why this rating

The statement reflects a consensus on the need for additional studies.

Source

Long-acting amylin analogues for the management of obesity

David S. Mathiesen et al. · Current Opinion in Endocrinology Diabetes and Obesity · 2022

DOI 10.1097/med.0000000000000716

reviewCited 37×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →